SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Frémeaux-Bacchi, V.
Right arrow Articles by Kazatchkine, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frémeaux-Bacchi, V.
Right arrow Articles by Kazatchkine, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus

V. Frémeaux-Bacchi

Service d'lmmunologie, INSERM U430 and Université Pierre et Marie Curie, Hôpital Broussais, 75014 Paris, France

L. Weiss

Service d'lmmunologie, INSERM U430 and Université Pierre et Marie Curie, Hôpital Broussais, 75014 Paris, France

C. Demouchy

Service d'lmmunologie, INSERM U430 and Université Pierre et Marie Curie, Hôpital Broussais, 75014 Paris, France

J. Blouin

Service d'lmmunologie, INSERM U430 and Université Pierre et Marie Curie, Hôpital Broussais, 75014 Paris, France

MD Kazatchkine

Service d'lmmunologie, INSERM U430 and Université Pierre et Marie Curie, Hôpital Broussais, 75014 Paris, France

We have investigated the presence of autoantibodies to the collagen-like region (CLR) of C1q and its relationship with classical pathway-dependent hypocomplementemia in patients with SLE. Antibodies to CLR/C1q were quantitated in the plasma of 113 unselected patients with SLE by ELISA, using purified CLR as antigen. Plasma concentration of C3, CH50 activity and C2 hemolytic activity were determined according to standard pro cedures. The prevalence of 1gG antibodies to CLR/C1q in the study population was 33.6%. Plasma titers of anti-CLR/C1q autoantibodies showed a strong negative correlation with CH50 activity (p < 0.0001) and with plasma levels of C3 ( p < 0.0001). Eighty-five percent of patients with severe complement consumption exhibited high titers of anti-CLR/C1q anti bodies in plasma, independently of clinical disease activity. Anti-CLR/C1q antibodies were present in the plasma of 38% of patients with moderate classical pathway consumption and 14% of patients with no evidence of complement consumption. Analysis of sequential samples from six patients over a period of 18 to 24 months demonstrated that changes in CH50 activity mirrored those of the plasma titers of anti-CLR/C1q antibodies. Acquired hypocomplementemia through the classical pathway is strongly associated with the pres ence of anti-CLR/C1q autoantibodies in SLE. The results suggest that anti-CLR/C1q anti bodies may perpetuate classical pathway activation, independently of clinical disease activity.

Key Words: systemic lupus erythematosus • anti-C1q autoantibodies • complement activation

Lupus, Vol. 5, No. 3, 216-220 (1996)
DOI: 10.1177/096120339600500309
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement